| ¿µ¹® | staphylococcus | ÇÑ±Û | Æ÷µµ¾Ë±Õ, Æ÷µµ»ó±¸±Õ |
|---|---|---|---|
| ¼³¸í | ±×¶÷¾ç¼º ¾Ë±ÕÁß ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î¼ ¹è¾ç½Ã Æ÷µµ¼ÛÀÌ ¸ð¾çÀÇ µ¢¾î¸®¸¦ Çü¼ºÇÏ´Â °ÍÀÌ Æ¯Â¡Àû. Æ÷µµ¾Ë±Õ¼ÓÀÇ ´ëÇ¥ÀûÀÎ ±ÕÀ¸·Î¼´Â S. aureus, S. epidermidis, S. saprophyticus°¡ ÀÖÀ½. ¹è¾ç Ư¼ºÀº »ê¼Ò°¡ Á¸ÀçÇϴ ȯ°æ¿¡¼ »¡¸® ÀÚ¶ó¸ç īŻ¶óÁ¦(catalase)¸¦ »ý¼ºÇÏ´Â °ÍÀÌ »ç½Ç»ó±¸±Õ°úÀÇ Â÷ÀÌÁ¡À̸ç ź¼öȹ°À» ¹ßÈ¿½ÃÄÑ ¶ôÆ®»êÀ» »ý¼ºÇϳª °¡½º´Â »ý¼ºÇÏÁö ¾ÊÀ½. ƯÈ÷ S. aureus´Â ÄھƱֶóÁ¦(coagulase)¸¦ »ý¼ºÇÏ´Â °ÍÀÌ Â÷ÀÌÁ¡. Ç׿ø ±¸Á¶ |
||
| ¿µ¹® | nasal bone | ÇÑ±Û | ÄÚ»À |
|---|---|---|---|
| ¼³¸í | ÄڻѸ®ÀÇ ±âÃʸ¦ ÀÌ·ç´Â »ç´Ù¸®²ÃÀÇ ¾ãÀº »À·Î Á¿ì ÇÑ ½ÖÀÇ ¹°··»ÀÀ̸ç, Á¤Áß¾Ó¼±¿¡¼ ºÙ¾î ÀÖ´Ù. ÄÚ»ÀÀÇ À¸ð¼¸®´Â À̸¶»À, ¾Æ·¡¸ð¼¸®´Â ÄÚ¼±¹Ý¿¬°ñ, °¡Âʸ𼸮´Â À§ÅλÀÀ̸¶µ¹±â¿Í Á¢ÇÑ´Ù. ¹Ù±ù¸éÀº ÆòȰÇÏÁö¸¸ ¼Ó¾È¸éÀº ¿ä¸éÀ» ÀÌ·ç¸ç, ¼¼·Î·Î °ÉÄ£ ¹úÁý»À½Å°æ±¸´Â ÄÚ»À±¸¸ÛÀ¸·Î ¿¬°áµÇ¾î ¾Õ¹úÁý»À½Å°æ°ú ÅëÇÑ´Ù. |
||
| ¿µ¹® | epistaxis, nasal bleeding | ÇÑ±Û | ÄÚÇÇ, ºñÃâÇ÷ |
|---|---|---|---|
| ¼³¸í | ºñÃâÇ÷À̶õ ¸»±×´ë·Î ÄÚ¿¡¼ Çǰ¡ ³ª´Â °ÍÀÌ´Ù. ÀÌ ÄÚÇÇ¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖ´Ù. ÀϹÝÀû ¿øÀÎÀ¸·Î´Â Ç÷¾×º´, ¼øÈ¯±âº´, °í¿, ±â¾ÐÀÇ º¯È µîÀ» µé ¼ö ÀÖ°í ¿ù°æÀ̳ª ³úÃâÇ÷ÀÇ ´ë»óÀ¸·Î ³ª¿À´Â Àϵµ ÀÖÀ¸³ª, ½ÇÁ¦·Î´Â ±¹¼ÒÀû ¿øÀÎÀÌ ÈξÀ ¸¹Àº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±¹¼ÒÀû ¿øÀÎÀ¸·Î´Â ¿øÀÎÀ» ¾Ë ¼ö ¾ø´Â Ư¹ß¼º ºñÃâÇ÷ÀÌ °¡Àå ¸¹°í, ¿Ü»ó, ¿°Áõ, ¾ÏµîÀÌ ¿øÀÎÀϼö ÀÖ´Ù. ÃâÇ÷Àº ¾à 90%°¡ ºñÁß°ÝÀÇ Àü´Ü¿¡ Àִ Ű¼¿¹ÙÈå¾ó±â(Kiesselbach's plexus)¿¡¼ ³ª¿Â´Ù. À̰÷Àº ¿©·¯ °¡Áö µ¿¸ÆÀÌ ¸ð¿© ÀÖ´Â °÷À¸·Î ¿ø·¡ Ç÷·ù°¡ ¸¹¾Æ ÃâÇ÷ÀÇ ¼ÒÁö°¡ ¸¹Àº °÷ÀÌ´Ù. ³ª¸ÓÁö 10%´Â ÄÚ¾ÈÀÇ ´Ù¸¥ ºÎÀ§¿¡¼ ³ª¿Ã ¼ö ÀÖ°í, ƯÈ÷ µÞºÎºÐ¿¡¼ ³ª¿À´Â °æ¿ì´Â ÀÔÀ¸·Î Çǰ¡ Èê·¯³»¸®°í, È®½ÇÇÑ ÃâÇ÷ ºÎÀ§¸¦ Á¤È®È÷ °üÂûÇÒ ¼ö ¾ø´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ °£´ÜÇÑ Ä¡·á·Î´Â ÇØ°áµÇÁö ¾Ê´Â ¶§°¡ ¸¹´Ù. |
||
| MRSA | Methicillin Resistant Staphylococcus Aureus Tx 1. Bactrim(TMP/SMX) + ... |
|---|---|
| S. | 1) Staphylococcus; Æ÷µµ±¸±Õ(¼Ó) S. albus; ¹é»öÆ÷µµ»ó±¸±Õ &... |
| MARSA | methicillin-aminoglycoside-resistant Staphylococcus aureus |
| MRSA | methicillin-resistant Staphylococcus aureus |
| MSSA | methicillin-sensitive Staphylococcus aureus |
| S aureus | Staphylococcus aureus |
|---|---|
| nasal CPAP | Nasal continuous positive airway pressure |
| MRSA | Methicilin resistant Staphylococcus Aureus |
| MRSA | Methicillin Resistant Strains of Staphylococcus Aureus |
| MSSA | Methicillin sensitive Staphylococcus aureus |
| staphylococcus aureus | Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications. (12 Dec 1998) |
|---|---|
| Staphylococcus aureus neutral proteinase | <enzyme> Included in the group of microbial metalloproteinases EC 3.4.24.4; ptrb protein is isolated from E coli; sakstar is recombinant staphylokinase Pharmacological action: fibrinolytic agents Registry number: EC 3.4.24.- Synonym: protease II, staphylokinase, staph aureus protease, staphylococcal protease, E coli protease, ptrb protein, sakstar, (26 Jun 1999) |
| Staphylococcus pyogenes aureus | Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications. (12 Dec 1998) |
| Staphylococcus | <bacteria> Genus of nonmotile gram-positive bacteria that are found in clusters and that produce important exotoxins. Staphylococcus aureus (Staphylococcus pyogenes) is pyogenic, an opportunistic pathogen and responsible for a range of infections including severe sepsis, pneumonia, endocarditis and soft tissue infections. It has protein A on the surface of the cell wall. Coagulase production correlates with virulence: hyaluronidase, lipase and staphylokinase are released in addition to the toxins. (27 Sep 1997) |
| staphylococcus antitoxin | A preparation from native serum containing antitoxic globulins or their derivatives that specifically neutralise the lethal, skin-necrosing, and haemolytic properties of the alpha-toxin of Staphylococcus aureus. (05 Mar 2000) |
| staphylococcus epidermidis | A species of staphylococcus that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader. (12 Dec 1998) |
| Staphylococcus food poisoning | Outbreaks commonly caused by staphylococcal enterotoxin and characterised by an abrupt onset of gastroenteritis within several hours after ingestion of the food contaminated with the preformed exotoxin; vomiting is usually more severe and diarrhoea less severe than in infectious forms of bacterial food poisoning. (05 Mar 2000) |
| Staphylococcus haemolyticus | Coagulase-negative staphylococcus indigenous to human and mammalian hosts. (05 Mar 2000) |
| Staphylococcus hominis | Coagulase-negative staphylococcus indigenous to human and mammalian hosts. (05 Mar 2000) |
| Staphylococcus hyicus | A species whose porcine subspecies are opportunistic pathogens associated with epidermites such as greasy pig disease. (05 Mar 2000) |
| staphylococcus phages | Viruses whose host is staphylococcus. (12 Dec 1998) |
| Staphylococcus pyogenes albus | A name formerly applied to the organisms which are now regarded as the mutants of Staphylococcus aureus which form white colonies. (05 Mar 2000) |
| Staphylococcus saprophyticus | A genus that causes urinary tract infections. (05 Mar 2000) |
| Staphylococcus simulans | Coagulase-negative staphylococcus indigenous to human and mammalian hosts. (05 Mar 2000) |
| staphylococcus vaccine | A suspension of organisms from cultures of one or more strains of Staphylococcus; used for furunculosis, acne, and other suppurative conditions. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|